Página 2 - Melhores Diagnóstico abrangente de linfomas médicos - TOP-43 médicos

Dr. Sridhar P.S. is a skilled radiation oncologist. He earned his Bachelor of Medicine from Mysore University. He completed his MD in Radiotherapy at Banaras Hindu University. He also holds a Diplomate of the National Board in Radiotherapy. This shows his advanced training and dedication to quality care.

Dr. Sridhar is a member of several professional groups. These include the Association of Radiation Oncology of India, Society for Neuro-Oncology, Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology. He is known for his effective cancer treatments and focus on new therapies. His work has made a positive impact in the field of oncology.

Dr. Antonio Cubillo Gracián is a specialist in Medical Oncology. He has broad teaching and clinical experience at USP CEU and HM CIOCC. He has directed postgraduate research as Director of the Master’s in Clinical and Applied Research in Oncology. Since 2009, he has tutored more than 100 students, residents, and rotating staff.

Dr. Cubillo has advanced oncology education by teaching subjects such as General Medical Pathology, Oncology, Bioethics, and Pathophysiology. He has organized international courses on digestive neoplasms. He has also worked with leading institutions, including MD Anderson Cancer Center. His academic leadership and clinical mentorship have set high standards in oncology training and research.

Dr. Shaunak Valame is an MD in Internal Medicine and holds a DNB in Medical Oncology. He received advanced training at Indraprastha Apollo Hospital in New Delhi. He also worked as a Registrar at Jawaharlal Nehru Cancer Hospital in Bhopal. Dr. Valame has presented his research at international forums, including the Gastrointestinal Cancer Symposium in San Francisco.

He is known for his work in targeted cancer therapies. He has given lectures at the International Winter School of Oncology at AIIMS Bhopal. Dr. Valame is accredited by the American Society of Clinical Oncology. He is committed to advancing cancer research and clinical care.

Dr. Lalit Banswal is an experienced oncological surgeon with 10 years in the field. He has performed more than 10,000 major surgeries. He earned his MBBS from MIMER, Pune, and completed his MS at GMC Panaji. He also completed a fellowship in Surgical Oncology at Tata Medical Centre, Kolkata, with a focus on gastrointestinal cancers.

Dr. Banswal has worked as a Co-principal Investigator in several research projects. He has published his work in both national and international journals. He is known for his patient-friendly and ethical approach. His main expertise is in Minimal Invasive Cancer Surgeries, where he consistently delivers excellent results.

Dr. Ahmer Arif Shaikh, MDS (Oral & Maxillofacial Surgery), is a specialist in Surgical Oncology. He has 3 years of experience at HCG Manavata Cancer Centre, Nashik. He focuses on oral cancer treatment, organ preservation, and functional rehabilitation for oral cancer patients.

Dr. Shaikh has completed a Fellowship in Head & Neck Surgical Oncology. He is skilled in complex maxillofacial and head & neck surgeries. He is also an active researcher with several publications in reputed journals. His work shows a strong commitment to improving cancer care.

Dr. Prakash Pandit is an MD in Radiation Oncology and works as a Consultant. He has expertise in advanced cancer treatments. He specializes in Tomotherapy-H, Linear Accelerator, and Brachytherapy. He provides modern care for various types of cancer.

Dr. Pandit is known for his work in radiation oncology. He uses the latest technology to help patients. He has treated many complex cases. He always maintains high standards of safety and accuracy in his treatments.

Dr. Shruti Kate is an experienced oncologist. She specializes in treating lung, breast, gynecological, and genitourinary cancers. She earned her MBBS from Lady Hardinge Medical College. She completed her MD in Internal Medicine at Maulana Azad Medical College. She also holds a DM in Medical Oncology from Tata Memorial Hospital, Mumbai.

Dr. Kate has managed both conservative and surgical cancer treatments. She is skilled in complex procedures such as the Whipple surgery. She is a member of several leading oncology societies, including ASCO, ESMO, IASCLC, ISMPO, and IOS. Her research on lung cancer received the only travel award from India at the 2018 World Conference on Lung Cancer.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Dra. Viola Fox é a Médica Chefe da Clínica de Hematologia, Oncologia e Medicina Paliativa no BKZ Solingen. Esta clínica é um centro de câncer interdisciplinar certificado. A Dra. Fox é uma especialista de destaque em terapia medicamentosa para doenças tumorais na Alemanha e na Europa. Ela tem mais de 15 anos de experiência nesta área.

Ela é membro da Sociedade Alemã de Oncologia e Hemato-oncologia (GDHO), da Associação Alemã de Médicos e da American Association for Cancer Research. A Dra. Fox também é ativa na pesquisa em biologia molecular. Seu trabalho apoia o progresso no tratamento do câncer e nos diagnósticos moleculares.

As suas principais áreas de especialização são a quimioterapia, a imunoterapia, a terapia alvo e a radioterapia. A Dra. Fox é conhecida por seus métodos inovadores e forte compromisso com o cuidado ao paciente. Seus esforços levaram a altas taxas de recuperação e reconhecimento de seus pares.

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Prof. Dr. Şebnem İzmir Güner was born in 1970 in Istanbul and took her first steps in her medical career at Istanbul University Faculty of Medicine. Successfully completing her undergraduate and medical education here between 1987-1993, Güner received her internal medicine specialty training at Istanbul University Cerrahpaşa Faculty of Medicine from 1995 to 2000. Deepening her interest in hematology, Prof. Dr. Güner completed her hematology subspecialty training at Cerrahpaşa Faculty of Medicine again between 2003-2006, solidifying her expertise in this field.
Prof. Dr. Güner’s professional journey began as an internal medicine specialist at Istanbul Education and Research Hospital from 2000 to 2003. She established the Hematology Clinic at the same hospital from 2006 to 2010 and served as the responsible physician. Here, she developed innovative approaches in the treatment of patients and made significant contributions to the field of hematology. From 2010 to 2016, she established the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center at Medicalpark Bahçelievler Hospital and served as the responsible physician. During this period, she conducted studies that set national and international standards in the field of hematology.
Between 2016-2018, Prof. Dr. Güner took on similar roles at Şişli Kolon International Hospital, where she was also the founder and responsible physician of the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center. Güner, who became an associate professor in 2017, obtained her professorship title in 2023. Between 2019-2024, she worked at Memorial Şişli Hospital in the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center.
Prof. Dr. Şebnem İzmir Güner is recognized for her scientific contributions, with over 19 articles published in international peer-reviewed journals. Additionally, she has over 18 articles published in national peer-reviewed journals and 51 presentations at national scientific meetings that have been published in proceedings books. She has also made a name for herself in the academic world with over 18 presentations at meetings and published in proceedings books. Güner, who has held positions on the boards of domestic hematology associations and has active memberships, has crowned her success with more than three awards given at universities and conferences.
Prof. Dr. Şebnem İzmir Güner, who speaks English and German, is also recognized as an educator. In this capacity, she has contributed to the training of young doctors in the field of hematology, providing education to research assistant doctors and students.
Prof. Dr. Şebnem İzmir Güner has established a respected place in the field of hematology with her achievements and scientific contributions throughout her professional life, continuing her career as a physician who inspires her patients and colleagues.

MEDICAL INTERESTS

• Leukemia
• Lymphoma
• Multiple myeloma
• Bone marrow transplantation
• Anemia
• Bleeding and coagulation disorders
• Hemophilia

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Formação

• Faculdade de Medicina de Ege 1978
• Especialização em Pediatria 1982
• Subespecialidade em Oncologia Pediátrica 2002 (Faculdade de Medicina EU)
• Hematologia e Oncologia Pediátrica 2012 (Faculdade de Medicina EU)
• Chefe Adjunto de Clínica 1988 Tepecik EAH
• Chefe de Clínica 1993 Tepecik EAH
• Professor Associado 1995
• Professoria 2002
• Faculdade de Medicina da Universidade de Ege, membro do corpo docente 1998 – 2022
• Departamento de Pediatria da Faculdade de Medicina da UE 2009-2018
• Membro do Conselho de Planejamento e Coordenação de Educação Tepecik (1993-1998)
• Presidente do Comitê de Ética do SSI Hospital de Tepecik (1996-1998)
• Sociedade Turca de Hematologia Pediátrica "Co-Presidente do Grupo de Trabalho em Transplante de Medula Óssea" (2002-2006)
• Sociedade Turca de Hematologia Pediátrica "Grupo de Trabalho em Transplante de Medula Óssea" (2006-2008)
• Sociedade Turca de Hematologia Pediátrica - Responsável pelo Sistema de Registro de Dados "Online" de Transplante de Medula Óssea 2007-presente.
• Presidente da Comissão de Medicina Regenerativa e Células-Tronco da Universidade de Ege, 2011-2021

Filiações Institucionais

• Associação Médica Turca Ramo de Izmir e Kocaeli
• Associação Pediátrica Nacional Turca - İzmir
• Grupo Europeu para Transplante de Medula Óssea (EBMT); a Unidade de Transplante de Medula Óssea Pediátrica da Universidade de Ege foi credenciada pelo Grupo Europeu para Transplante de Medula Óssea (EBMT) em junho de 2007.
• Sociedade Turca de Hematologia Pediátrica - Membro do Conselho por dois mandatos (2005-2009)
• Sociedade Turca de Hematologia - Membro do Conselho por dois mandatos (2001/2005)
• Associação de Oncologia Pediátrica da Turquia
• Fundação de Transplante de Medula Óssea (KITVAK) Membro do Conselho de Curadores

Unidades que ele fundou                        

1- Clínica de Oncologia Pediátrica do SSI Hospital de Tepecik (1990) 
2- Unidade de Transplante de Medula Óssea Pediátrica do SSI Hospital de Tepecik (1992) 
3- Unidade de Transplante de Medula Óssea Pediátrica da Faculdade de Medicina da UE (1998) 
4- FUNDADOR do JOURNAL OF PEDIATRIC RESEARCH, 2014; foi feita a aplicação SCI em 2022. 

Unidades de Transplante que ele contribuiu para o estabelecimento de                        

1. Unidade de Transplante de Medula Óssea Pediátrica do İzmir BUÇH EAH (2019) 
2. Unidade de Transplante de Medula Óssea Pediátrica do Ümraniye EAH (2020) 
3. Unidade de Transplante de Medula Óssea Pediátrica do Kanuni Sultan Süleyman EAH (2020) (Transferida para Çam Sakura EAH)

Prémios

• Parâmetros trombóticos em pacientes com transplante de células-tronco de medula óssea, Congresso de Hematologia Pediátrica, Trabzon 2003
• Antígeno CD133 em Células-Tronco: Congresso de Hematologia Pediátrica 2005. Prémio de pesquisa
• O papel dos Receptores Toll-like em pacientes neutropênicos febris, Prémio de melhor poster. Congresso de Hematologia Turca 2008, Çeşme-İzmir
• Atividade nacional de transplante de células-tronco pediátrico- Apresentação oral segundo prémio, Congresso de Transplante de Células-Tronco da Sociedade de Hematologia Turca, 2022, Antalya

Publicações

Kansoy S. "Transplante de Medula Óssea e Células-Tronco Saúde Infantil e Doenças, 1ª edição, Casa de Impressão da Faculdade de Medicina da UE, 1999, Izmir

Kansoy S. Transplante de Medula Óssea na Talassemia Major III. Livro dos Dias de Talassemia do Egeu, 2000, Izmir

Kansoy S. Padrões da Pediatria KIT na Turquia. Leucemias Agudas da Infância, Antalya 2000: 73-5

Kansoy S. Efeitos tardios em crianças. Edição especial do Jornal de Transplante de Medula Óssea Clínicas Turcas. 2003

Kansoy S. Aplicações de Células-Tronco em Transplante de Medula Óssea e Células-Tronco. Livro do Curso de Enfermagem Oncológica Pediátrica, İzmir, 2005

Kansoy S. Sangue do Cordão Umbilical como Fonte de Células-Tronco. Edição Especial de Células-Tronco. Clínicas da Turquia, 2008

Kansoy S. Transplante de Células-Tronco em Linfomas. Livro de Pediatria Geral, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Transplante de Medula Óssea em Crianças. Pediatria, 2014 e 2017

Kansoy S. Rabdomiossarcoma. Pediatria, 2014 e 2017

Kansoy S. Abordagem à criança com câncer de acordo com os achados clínicos. Pediatria, 2014 e 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Doenças Oncológicas. Pediatria (Ed. A. Cura), 641-672, Casa de Impressão da Universidade de Ege, Izmir, 1999.  (1,05 pontos)

Kansoy S, M.Kantar. Exame de Cabeça, Face e Olho. Exame Físico Prosético Pediátrico e Informação de Sintomas (Ed. A.Cura)

Kantar M. Problemas de Emergência Metabólica em Oncologia. Emergências Oncológicas e Cuidados de Apoio na Infância (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, Izmir, 2003. 

Transplantes de Sangue do Cordão Umbilical na Turquia. HEMATOLOGISTA, 2016

Kansoy S. Tumores do Sistema Nervoso Central em Crianças Pediatria, 2014 e 2017

Leucemia Mieloblástica Aguda em Crianças e seu Tratamento. Livro Textbook de Oncologia Pediátrica, Turco de Poplack, 2020

Atividade nacional de transplante de células-tronco pediátrico, 2020

Indicações de transplante de células-tronco na infância, Clínicas da Turquia - Livro Internacional 2020

Além dos estudos e artigos em revistas internacionais publicadas em grande número, ele está envolvido em estudos multicêntricos internacionais em algumas revistas com alto valor de impacto.

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Nichakorn Seehirunwong, M.D.

Radiologist

Graduated (M.D. From)

Doctor of Medicine, Faculty of Medicine, Prince of Songkla University

• Interpreting the results of medical imaging tests.
• Comparing medical image findings with other examinations and tests.
• Consulting with your referring healthcare provider (the provider who ordered the imaging tests) to help choose the proper imaging test and using test results to inform your medical care. Writing reports of results and diagnoses.
• Recommending additional examinations or treatments when necessary.
• Treating diseases by using radiation (radiation oncology) or imaging-guided procedures (interventional radiology). Performing or directing radiology staff to carry out imaging tests.

Certificates

Certificate of Diagnostic Radiology, Faculty of Medicine, Prince of Songkla University

Current Positions

Diagnostic Radiologist at Intrarat Hospital